Cannell & Spears’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-1,318
Closed -$206K – 422
2025
Q2
$206K Buy
1,318
+2
+0.2% +$317 ﹤0.01% 369
2025
Q1
$217K Sell
1,316
-13
-1% -$2.16K ﹤0.01% 358
2024
Q4
$217K Sell
1,329
-263
-17% -$47K ﹤0.01% 365
2024
Q3
$311K Hold
1,592
– – 0.01% 339
2024
Q2
$276K Hold
1,592
– – 0.01% 316
2024
Q1
$269K Buy
1,592
+100
+7% +$18.7K 0.01% 330
2023
Q4
$294K Buy
1,492
+100
+7% +$17.7K 0.02% 173
2023
Q3
$242K Hold
1,392
– – 0.02% 181
2023
Q2
$240K Buy
+1,392
New +$241K 0.02% 198

Other funds holding ZTS

Cannell & Spears's ZTS Position: Q3 2025 in Review

Cannell & Spears sold out of Zoetis (ZTS) in Q3 2025, closing a stake of 1,318 shares — an estimated $206K sold.

Cannell & Spears first reported a position in ZTS in Q2 2023 and held it in 9 quarters. The position peaked at $311K in Q3 2024. 1,806 funds tracked by Wall St. Rank hold ZTS as of Q3 2025.

  • Cannell & Spears reported no remaining Zoetis position as of Q3 2025 after selling out during the quarter.
  • Cannell & Spears sold 1,318 Zoetis shares in Q3 2025, an estimated $206K.
  • Cannell & Spears first reported a position in Zoetis in Q2 2023 and held it in 9 quarters.
  • Cannell & Spears's Zoetis position peaked at $311K in Q3 2024.
  • 1,806 funds tracked by Wall St. Rank held Zoetis as of Q3 2025.

Based on Cannell & Spears's 13F filing for Q3 2025, filed 14 Nov 2025.